Indivior Pharmaceuticals Inc
INDV
Pozycja w akcjach
#4015
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Cena akcji
$32.56
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$4.06B
Zmiana (1 dzień)
-3.15%
Zmiana (1 rok)
33.01%
Kraj
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategoria
Healthcare
EPS dla Indivior Pharmaceuticals Inc (INDV)
EPS na dzień June 2026 TTM: $2.84
Według najnowszych raportów finansowych i ceny akcji firmy Indivior Pharmaceuticals Inc, obecny EPS (TTM) wynosi $2.84. Na koniec roku 2023 firma miała EPS w wysokości $0.01, wzrost w porównaniu do do EPS z roku 2022, który wynosił $-0.37.
Historia EPS dla Indivior Pharmaceuticals Inc od 2016 do 2026
EPS na koniec każdego roku
| Rok | EPS | Zmień |
|---|---|---|
| 2026 (TTM) | $2.84 | 14,100.00% |
| 2024 | $0.02 | 3.42% |
| 2023 | $0.01 | -103.95% |
| 2022 | $-0.37 | -126.81% |
| 2021 | $1.38 | -227.78% |
| 2020 | $-1.08 | -213.68% |
| 2019 | $0.95 | -47.51% |
| 2018 | $1.81 | 330.95% |
| 2017 | $0.42 | 90.91% |
| 2016 | $0.22 | 0.00% |
EPS dla podobnych firm lub konkurentów
| Firma | EPS | Różnica w EPS | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | -80.41% |
IN
|
